Spero Therapeutics, Inc. SPRO Q1 2025 earnings
Reported May 13, 2025 · After market close
Revenue$5.9MMiss by $5.1M
EPS-$0.25Beat by $0.30
Revenue estimate$11.0M
EPS estimate-$0.55
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$281.9K
EPS estimate-$0.17
Versus estimates
Revenue
Diluted EPS
Ask the moment Spero Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Spero Therapeutics, Inc. report Q1 2025 earnings?
- Spero Therapeutics, Inc. (SPRO) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were Spero Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Spero Therapeutics, Inc. reported revenue of $5.9M and eps of $-0.25 for Q1 2025.
- Did Spero Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $11.0M by $5.1M. EPS beat the consensus estimate of $-0.55 by $0.30.
- How did Spero Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 39.7% from $4.2M a year earlier and eps declined 4.2% from $-0.24.
- Where can I find Spero Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-070380) directly on SEC EDGAR. The filing index links above go to sec.gov.